Summary
Kardium Inc (Kardium) is a medical device company that develops ground breaking medical device for the diagnosis and treatment of atrial fibrillation. The company's product include globe mapping and ablation system, a comprehensive solution for atrial fibrillation treatment that combines single shot pulmonary vein isolation, high-definition mapping, and atrial ablation in a single catheter. Its products are used in healthcare industry by medical professionals specializing in heart rhythm disorders. Kardium is headquartered in Burnaby, British Columbia, Canada.This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Kardium Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Kardium Inc Company Overview
- Kardium Inc Company Snapshot
- Kardium Inc Pipeline Products and Ongoing Clinical Trials Overview
- Kardium Inc - Pipeline Analysis Overview
- Kardium Inc - Key Facts
- Kardium Inc - Major Products and Services
- Kardium Inc Pipeline Products by Development Stage
- Kardium Inc Ongoing Clinical Trials by Trial Status
- Kardium Inc Pipeline Products Overview
- CHS - Coated Globe Mapping And Ablation System
- CHS - Coated Globe Mapping And Ablation System Product Overview
- Globe Mapping And Ablation System
- Globe Mapping And Ablation System Product Overview
- Globe Mapping And Ablation System Clinical Trial
- Globe PF System
- Globe PF System Product Overview
- Globe PF System Clinical Trial
- Percutaneous Mitral Valve Regurgitation Device
- Percutaneous Mitral Valve Regurgitation Device Product Overview
- Kardium Inc - Key Competitors
- Kardium Inc - Key Employees
- Kardium Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Kardium Inc, Recent Developments
- May 31, 2024: Kardium Shows Positive Results in the 1-Year Follow-up of PULSE-EU
- May 29, 2024: Kardium Announces Positive 1-Year Outcomes for PULSE-EU Trial with the Globe System, Showing Promise for Improving the Treatment of Atrial Fibrillation
- May 09, 2024: Kardium Announces Enhanced Clinical Capabilities of the Globe System with Right Atrial Ablation and Hybrid Energy Ablation
- Apr 02, 2024: Kardium Announces Completion of Paroxysmal Enrollment in the PULSAR IDE Study
- May 31, 2023: Kardium announces first US procedures in PULSAR study of Globe Pulsed Field System
- Mar 15, 2023: Kardium announces first patients treated in PULSAR IDE study of Globe Pulsed Field System
- Nov 09, 2022: Kardium completes Globe PF System first-in-human clinical study
- Apr 12, 2022: Kardium’s Globe System begins clinical trial at St. Paul's Hospital
- Dec 15, 2021: First-in-human trial of pulsed field ablation with Kardium’s Globe PF system
- Jan 26, 2021: Canada’s Kardium wins $115m funding for Globe mapping and ablation system
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Kardium Inc Pipeline Products and Ongoing Clinical Trials Overview
- Kardium Inc Pipeline Products by Equipment Type
- Kardium Inc Pipeline Products by Indication
- Kardium Inc Ongoing Clinical Trials by Trial Status
- Kardium Inc, Key Facts
- Kardium Inc, Major Products and Services
- Kardium Inc Number of Pipeline Products by Development Stage
- Kardium Inc Pipeline Products Summary by Development Stage
- Kardium Inc Ongoing Clinical Trials by Trial Status
- Kardium Inc Ongoing Clinical Trials Summary
- CHS - Coated Globe Mapping And Ablation System - Product Status
- CHS - Coated Globe Mapping And Ablation System - Product Description
- Globe Mapping And Ablation System - Product Status
- Globe Mapping And Ablation System - Product Description
- Globe Mapping And Ablation System - An Investigational Clinical Study of Globe Mapping and Ablation System in Treatment of Patients with Atrial Fibrillation
- Globe Mapping And Ablation System - PULSE-EU - A Prospective, Non-randomized Clinical Pilot Study to Assess Safety and Performance of a Pulsed Field Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation
- Globe PF System - Product Status
- Globe PF System - Product Description
- Globe PF System - A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Globe Pulsed Field System for Treating Patients with Symptomatic Paroxysmal or Persistent Atrial Fibrillation
- Percutaneous Mitral Valve Regurgitation Device - Product Status
- Percutaneous Mitral Valve Regurgitation Device - Product Description
- Kardium Inc, Key Employees
- Glossary
- Kardium Inc Pipeline Products by Equipment Type
- Kardium Inc Pipeline Products by Development Stage
- Kardium Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Keir Surgical Ltd
- Clark Medical Products Inc
- Canadian Medical Products Ltd
- Braebon Medical Corp
